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the nucleus. Nuclear receptors lack a leucine-rich nuclear export signal
(NES), and export is insensitive to leptomycin B, indicating that nuclear
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Results: We set out to define the NES in the glucocorticoid receptor (GR)
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DNA binding domain (DBD) of GR, which is unrelated to any known NES, Accepted: 27 September 2001
is necessary and sufficient for export. Mutational analysis revealed that a
15 amino acid sequence between the two zinc binding loops in the GR- Published: 13 November 2001
DBD confers nuclear export to a GFP reporter protein, and alanine-
Current Biology 2001, 11:1749–1758scanning mutagenesis was used to identify the residues within this sequence
that are critical for export. The DBD is highly related (41%–88% identity) in
0960-9822/01/$ – see front mattersteroid, nonsteroid, and orphan nuclear receptors, and we found that the
 2001 Elsevier Science Ltd. All rights reserved.DBDs from ten different nuclear receptors all function as export signals.
DBD-dependent nuclear export is saturable, and prolonged nuclear
localization of the GR increases its transcriptional activity.
Conclusions: Multiple members of the nuclear receptor superfamily use a
common pathway to exit the nucleus. We propose that NLS-mediated
import and DBD-mediated export define a shuttling cycle that integrates the
compartmentalization and activity of nuclear receptors.
Background cells induces the cytoplasmic accumulation of GR and
AR [6, 9]. Moreover, in the presence of ligand whereNuclear receptors contain a structurally conserved DBD
that contacts the respective DNA response element nuclear receptors appear constitutively nuclear, GR, AR,
thyroid hormone receptor (TR), and the progesteronewithin enhancers of target genes [1–3]. Ligand-occupied
nuclear receptors interact with transcriptional coactiva- receptor (PR) are rapidly shuttling between the nucleus
and cytoplasm [6, 10–13]. Because the sizes of these andtors, whereas ligand-free nuclear receptors interact with
transcriptional repressors. Ligand binding has, in addition, other nuclear receptors (43–90 kDa) exceeds the mo-
lecular weight cutoff for simple diffusion through thea profound influence on the subcellular distribution of
certain nuclear receptors [4]. Glucocorticoid binding to nuclear pore, it has been inferred that nuclear export of
nuclear receptors is a facilitated process. The balance of nu-GR induces receptor translocation from the cytoplasm to
the nucleus [5], and androgen induces translocation of clear import and export could be an important mechanism
for regulating the transactivation potential of nuclear re-the androgen receptor (AR) to the nucleus as well [6].
Nuclear import occurs because ligand binding to nuclear ceptors. Indeed, selective nuclear localization of factors
involved in signal transduction and transcription hasreceptors releases chaperones and exposes one or more
NLSs. GR contains two ligand-regulated NLSs, one of emerged as an important regulatory step in several biologi-
cal pathways [14].which is located in the hinge region adjacent to the DBD
[5]. The NLS is, in turn, recognized by nuclear import
The best-characterized nuclear export pathway usesCrm1factors that facilitate translocation of the nuclear receptor
as a receptor for proteins that contain a leucine-rich NES.through the nuclear pore complex and delivery to the
Nuclear receptors such as GR, AR, TR, and PR do not,nucleoplasm [7, 8].
however, contain a leucine-rich NES, suggesting that
these proteins are not transport substrates for Crm1. ThisCertain nuclear receptors have also been shown to un-
dergo export from the nucleus. Hormone withdrawal from view is corroborated by the observation that the Crm1-
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specific inhibitor leptomycin B does not inhibit nuclear specified by the DBD, there may be a contribution to
theDBD structure that augments recognition of the signalexport of GR, PR, AR, or TR in mammalian cells [9, 13,
by the export machinery.15–17]. Recent insight into how nuclear receptors may
exit the nucleus came from a biochemical screen for nu-
Alanine-scanning mutagenesis of the DNA recognitionclear export factors present in extracts prepared from
helix between the loops revealed that a pair of phenylala-mammalian cells [17]. The calcium binding protein calret-
nines is critical for the export function of the DBDiculin (CRT) was identified as a factor that stimulates
(FF→AA; Figure 2). Mutating other pairs of amino acidsnuclear export of proteins that contain a leucine-rich NES
between the zinc fingers (KR→AA, VE→AA, and[17]. The previous link between CRT and downregula-
YL→AA) impaired the nuclear export function of the GRtion of GR, AR, all-trans retinoic acid receptor (RAR), and
DBD to a lesser degree (2 and 4 hr time points). Invitamin D receptor (VDR) transcriptional activity [18–20]
contrast, other mutations (KV→AA, GQ→AA, andsuggested a potential role in the export of nuclear recep-
HN→AA) had no effect on the export activity of the GRtors as well, despite the absence of a leucine-rich NES
DBD. Our data show that amino acids between the twoin these proteins. Recombinant CRT stimulates nuclear
zinc binding loops, which include part of the DNA recog-export of GR in permeabilized cell assays, and GR export,
nition helix, contain the NES of GR.which is deficient in crt/ cells, can be complemented
by back-transfecting CRT [17].
Steroid, nonsteroid, and orphan receptors use a common
export pathwayHere we characterize the signal for nuclear export of GR,
Our finding that the GRDBD contains theNES appearedwhich is contained within its DBD. Moreover, the DBD
significant in light of the structural conservation of thefunctions as the export signal in multiple steroid, nonste-
DBD among nuclear receptors. The GR DBD is at leastroid, and orphan nuclear receptor family members. The
40% identical to the sequences of DBDs from nine differ-DBD export pathway is saturable, indicating that nuclear
ent nuclear receptors included in our analysis (Figure 1a).receptors compete for a limited number of soluble trans-
Moreover, every member of the nuclear receptor super-port factors, NPC binding sites, or both. Overexpression
family that has been identified to date contains a pair ofof the VDR DBD inhibits GR export and results in an
phenylalanines that are located at the same position rela-elevated transcriptional response ofGR to dexamethasone
tive to phenylalanines within the GR DBD. This led(Dex). Thus, the DBD export pathway contributes to the
us to hypothesize that the DBDs from diverse nuclearregulation of GR and probably other nuclear receptors
receptors can function as anNES.We tested this hypothe-through a nuclear transport-based mechanism.
sis by analyzing the export activity of DBDs from steroid,
nonsteroid, and orphan nuclear receptors. We found thatResults
nuclear export of the GFP reporter was conferred by the
The DBD of GR contains the NES
DBD derived from AR, estrogen receptor (ER), liver XThe DBD of GR can be incorporated into a green fluores-
receptor (LXR), PR, RAR, RevErb, retinoid X receptor
cent protein (GFP) reporter and can function as an NES (RXR), TR, and VDR (Figure 3). Nuclear export was not
when expressed in cultured cells [17]. The conserved conferred by the DBD derived from GATA1, a transcrip-
sequence and structure of the DBD in different nuclear tion factor that, like the nuclear receptors, contains two
receptors (Figure 1a,b) led us to hypothesize that the zinc binding loops in its DBD [21]. GATA1 is not, how-
DBD is widely used as an export signal. To address this ever, a member of the nuclear receptor superfamily based
hypothesis, we first mapped the molecular determinants on sequence or structure. Thus, our data identify the
of the 69 amino acid GR DBD that are necessary for DBD of nuclear receptors as a new type of NES. The
nuclear export by using a GFP reporter that undergoes DBD does not contain a leucine-rich NES that is recog-
ligand-dependent nuclear import (Figure 1c). Following nized by the export receptor Crm1, which may explain
ligand removal from the cell culture media, the distribu- why nuclear export of GR, PR, TR, and AR are insensitive
tion of the GFP reporter was recorded at 0, 2, 4, and 6 to leptomycin B [9, 13, 15–17].
hr by fluorescence microscopy. We found that cysteine
to alanine mutations that disrupt the zinc binding loops Mutations in the DBD block nucleocytoplasmic shuttling
and abolish DNA binding only slightly inhibited nuclear of nuclear receptors
export of the GFP reporter (C424A and C463A; Figure Our experiments demonstrated that theDBD is sufficient
2). This suggested that nuclear export might instead rely to mediate nuclear export in the context of the GFP
on the DNA recognition helix that is situated between reporter. To determine whether the DBD is necessary
the two zinc binding loops. Indeed, a GFP reporter that for export in the context of the receptor, we examined
contained only 15 amino acids of the GR DBD (442–456) nucleocytoplasmic shuttling of full-length, wild-type (wt)
underwent translocation from the nucleus to the cyto- GR, AR, and RAR, and of mutant forms of these receptors
plasm. Although the zinc binding loops of nuclear recep- that were predicted to be deficient for export. We de-
signed a modified-shuttling assay that, in a heterokaryontors do not contain information that is critical for export
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Figure 1
Conserved structure of the DBD and assay for nuclear export activity. GFP reporter and two-step assay for nuclear export in vivo. The vector
(a) Alignment of DBDs from nuclear receptors used in this study encodes a mutant form of Rev (M10) that contains a nonfunctional
and the percent identity to the DBD of human GR. Highly conserved NES fused to the ligand binding domain (LBD) of GR and GFP. Dex
residues (bold) including the cysteines that coordinate zinc binding induces nuclear import of the GFP reporter, which remains nuclear
(green) and the pair of phenylalanines that are present in the DNA after Dex withdrawal because the reporter lacks a functional NES. In-
recognition helix of all nuclear receptors (red) are indicated. (b) frame fusion of a DBD to the N terminus of the GFP reporter restores
Diagram of the GR DBD showing the position of the pair of nuclear export activity.
phenylalanines relative to the zinc binding loops. (c) Features of the
fusion, scores nuclear export from a donor nucleus and used contains the SV40 large T antigen NLS to direct
constitutive import, but it remains nuclear in the hetero-nuclear import into an acceptor nucleus. Prior to fusion
(Figure 4a, upper panels), the donor cells (human) were karyon because it does not contain a nuclear export signal
(Figure 4c, upper panels). Fusion of the GR DBD to thetransfected with GFP fusions of the receptors and treated
with the appropriate ligand to induce nuclear import. The reporter resulted in nucleocytoplasmic shuttling (Figure
4c, lower panels). Thus, the GR DBD is sufficient toacceptor cells (mouse) were labeled with a CellTracker
dye that, following its uptake, is converted to a membrane direct nuclear export of the GFP reporter.
impermeant form in the cytoplasm. After fusion (Figure
4a, lower panels), the cytoplasm of the heterokaryon fluo- We next transfected full-length nuclear receptors (GR,
resces red, and the GFP fusion (green) containing full- AR, and RAR) containing either a wt DBD or a mutant
length GR equilibrates between the human and mouse DBD (FF→AA) into donor cells, treated the cells with
nuclei because it undergoes shuttling, as previously shown ligand, and fused them with acceptor cells labeled with
[11]. The GFP reporter used in prior experiments to char- the CellTracker dye. The wt forms of GR, AR, and RAR
acterize the DBD (Figure 1c) undergoes nuclear import, equilibrated between nuclei in the heterokaryon fusion
but fails to undergo export and equilibrate between nuclei (Figure 4d), indicating that export of these nuclear recep-
in the heterokaryon because it lacks a functional NES. tors occurs even in the presence of ligand. The DBD
Nuclear export of the GFP reporter was restored by the mutant forms (FF→AA) of GR and AR, however, failed
GR DBD, resulting in equilibration of the reporter be- to equilibrate between nuclei in the heterokaryon fusion.
tween nuclei in the heterokaryon fusion (Figure 4b). Thus, export of GR and AR from the donor nuclei is
inhibited by changing only two amino acids within the
DBD of each nuclear receptor. Surprisingly, the DBDThe GFP reporter used in the experiments described
above contains the ligand binding domain of GR to direct mutant form of RAR still equilibrated between nuclei in
the heterokaryon fusion (Figure 4d). Because the DBDDex-dependent import. We used another GFP reporter,
which lacked any GR sequence, to formally test for the of RAR is sufficient to specify nuclear export of the GFP
reporter used in our analysis (Figure 2), we interpret thissufficiency of the DBD export signal. The GFP reporter
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Figure 2 as evidence that RAR export can occur by an alternative,
DBD-independent transport pathway. Nuclear export of
RXR in nerve cells can be facilitated by its binding partner
NGFI-B, an orphan nuclear receptor with three leucine-
rich NESs [22]. Nuclear export of the wild-type and mu-
tant forms of RAR, however, still occurs in the presence of
leptomycin B (data not shown). Certain nuclear receptors
may, therefore, be exported from the nucleus by more
than one transport pathway.
CRT binding to the GR DBD is required for nuclear export
Our results showing that the GR DBD functions as an
export signal together with our previous finding that GR
export is defective in crt/ cells suggested a molecular
mechanism for the transport pathway [17]. This could
involve CRT-dependent recognition of the GR DBD in
the nucleus and translocation of the complex to the cyto-
plasm. We reasoned that if CRT binding to the DBD is
an obligate step in GR export, then mutations within the
DBD that inhibit export might also inhibit the interaction
of GR with CRT. We tested this by using binding assays
with recombinant CRT and glutathione-S-transferase
(GST) fusions of the wt and mutant (FF→AA) forms of
the GR DBD. CRT bound to the wt DBD but displayed
only background binding to the GR DBDmutant protein
(Figure 5a). Crm1 did not bind to theGRDBD, consistent
with other data indicating that Crm1 is not the receptor
for nuclear export of GR [16, 17].
The net redistribution of GR from the nucleus to the
cytoplasm generally requires several hours in ligand-free
media; however, the kinetics of export can enhanced by
microinjecting recombinant CRT into cells [17]. We used
this approach to examine whether GR containing a wt or
mutant DBD would undergo CRT-dependent nuclear
export. Cos cells were transfected with GFP fused to full-
length GR (wt or FF→AAmutant) and treatedwith ligand
to induce nuclear import of GR. The cells were then
injected with CRT, and the distribution of GR was re-
corded by fluorescence microscopy 30 min postinjection.
The DBD of GR functions as an NES. The GFP reporter engineered
with the DBD of GR was transfected into Cos cells and assayed for
nuclear export. Images of living cells were recorded by fluorescence
microscopy at 0, 2, 4, and 6 hr following Dex withdrawal. The GFP
reporter alone (no DBD) remains nuclear during the course of the
experiment, while including the GR DBD (residues 418–486) in the
GFP reporter confers export by 4 hr. Point mutations in the GR DBD
(C424A or C463A) slightly reduced the level of export, evident at
4 hr. The 15 residue sequence (KVFFKRAVEGQHNYL; residues
442–456) that resides between the two zinc binding loops was
sufficient for export of the GFP reporter. Alanine-scanning mutagenesis
of residue pairs in the DBD revealed that the FF→AA mutation in the
DNA recognition helix causes a major defect in nuclear export. The
KR→AA, VE→AA, and YL→AA mutations have an intermediate
effect on nuclear export, and the KV→AA, GQ→AA, and HN→AA
mutations have no effect on nuclear export.
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Figure 3 We observed that injection of cells with CRT caused the
relocalization of wt GR from the nucleus to the cytoplasm
(Figure 5b, upper panels). In contrast, CRT injection into
cells expressing the GR DBD mutant (FF→AA) did not
affect GR distribution (Figure 5b, middle panels). Crm1
injection did not cause wt GR redistribution to the cyto-
plasm. Thus, a functional export signal within the DBD
is necessary for CRT-dependent translocation of GR from
the nucleus to the cytoplasm. Recombinant CRT can also
mediate nuclear export of GR in a permeabilized cell
assay [17], and this can be inhibited by the addition of
the DBD from VDR (Figure 5c). The ability of the DBD
from VDR to act as a competitive inhibitor of GR export
indicates that CRT recognizes similar molecular determi-
nants in the DBDs of different nuclear receptors.
Excess DBD blocks GR export and increases
transcription
Our finding that the VDR DBD can act as a competitive
inhibitor of GR export in permeabilized cells led us to
examine whether overexpression of the VDRDBD fused
to BFP would compete with the GR export pathway in
living cells. Because the DBD of VDR also contains an
NLS [23], it undergoes export and import but is concen-
trated in the nucleus at steady state. Expression of BFP
alone did not affect nuclear export mediated by the GR-
DBD examined at 0 and 5 hr (Figure 6, upper panels).
In contrast, expression of BFP-VDR DBD inhibited GR-
DBD export and resulted in nuclear accumulation of GR-
DBD (Figure 6, middle panels). This effect required a
functional DBD in VDR since mutating the conserved
pair of phenylalanines in the DBD reversed the inhibition
(Figure 6, lower panels). Our data support the hypothesis
that a common pathway is used for nuclear export of both
steroid (GR) and nonsteroid (VDR) nuclear receptors.
Inhibiting DBD-dependent export in vivo restricts GR
to the nucleus, thereby blocking the nucleocytoplasmic
shuttling cycle. This allowed us to examine whether block-
ing nuclear export could augment the GR-dependent
transcription by increasing its dwell time in the nucleus.
We also considered the possibility that nucleocytoplasmic
shuttling could be necessary for the transcriptional activity
of GR because, for example, cytoplasmic chaperones are
required for ligand binding. GR-dependent transcription
can be measured in the presence of excess VDR DBD
because VDR does not bind to a GRE [24]. The response
elements for GR and VDR differ in sequence, direction,
and spacing of the half-sites.
factor GATA1, which is similar in size to the nuclear receptors and
The DBDs of diverse nuclear receptors can all function as an NES. contains two zinc binding loops, does not confer nuclear export to
The DBDs from hormone, nonhormone, and orphan nuclear the GFP reporter. The DBDs from nine different nuclear receptors
receptors were analyzed for nuclear export activity in vivo by using (AR, ER, LXR, PR, RAR, RevErb, RXR, TR, and VDR) confer nuclear
the GFP reporter. The GFP reporter alone (no DBD) remains nuclear export activity to the GFP reporter.
during the course of the experiment. The DBD from the transcription
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Figure 4
The DBD export signal is necessary for
hormone receptor shuttling in vivo. (a)
Heterokaryon shuttling assays were performed
with Cos cells transfected with full-length GR
fused to GFP (FITC) and NIH 3T3 cells labeled
with the dye CellTracker CMTMR
(Rhodamine). When coseeded on coverslips
and fused by brief (30 s) incubation in
polyethylene glycol (Roche; 50% vol:vol), the
Cos and 3T3 cells fuse and fluoresce red.
Nucleocytoplasmic shuttling (export and
import) of the GFP reporter results in
equilibration of green fluorescence between
the donor Cos cell nuclei and the acceptor
3T3 cell nuclei within the heterokaryon.
Acceptor cell nuclei (white arrowheads) are
also distinguished by centromeric foci that
stained brightly with DAPI. (b) The GR DBD
restores shuttling behavior to the GFP reporter
that contains a nonfunctional NES. (c) The
GR DBD confers shuttling activity to a GFP
reporter that contains the SV40 large T
antigen NLS [38]. The GFP reporter contains
the streptavidin gene and assembles into a
160 kDa tetramer that is too large to escape
the nucleus by diffusion. (d) The DBD export
signal is necessary for nucleocytoplasmic
shuttling in the context of full-length hormone
receptors. Full-length wt or mutant (FF→AA)
GR, AR, and RAR were tested for
nucleocytoplasmic shuttling in the presence
of 1 M Dex, 10 nM R1881 (synthetic
androgen), or 1 M all-trans retinoic acid,
respectively. Each wt receptor equilibrates
between the nuclei of a heterokaryon. The
FF→AA mutation inhibits GR and AR
shuttling, whereas the FF→AA mutation has
only a slight effect on RAR shuttling. The
FF→AA mutation in the GR DBD abolishes
DNA binding in vitro, suggesting the mutation
does not generate a nuclear retention signal
(data not shown).
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Figure 5 GR-dependent transactivation of a GRE-luciferase re-
porter wasmeasured in the presence of cotransfected BFP
or BFP-VDR DBD as a function of Dex concentration
(Figure 7a). Expression of the BFP-VDR DBD increased
GRE luciferase activity 2-fold relative to BFP. Thus, in-
hibiting GR export results in an increase in GR-depen-
dent transcription. The effect was correlated with the
amount of BFP-VDR DBD plasmid used for cotransfec-
tion (Figure 7b). We also found that a mutant form of
the VDR DBD (FF→AA) that has reduced activity as a
competitive inhibitor of GR export (Figure 6) increases
the transcriptional activity of GR only slightly (Figure
7c). Our data indicate that nuclear export of GR is critical
for proper regulation of its transcriptional activity, since
blocking GR export results in an elevated response to
ligand. Moreover, nuclear export is predicted to be impor-
tant for regulating the cytoplasmic functions that are
emerging for certain nuclear receptors.
Discussion
In the context of a living cell, GR undergoes rapid ex-
change between chromatin binding sites and the nucleo-
plasm [25]. Upon dissociating from chromatin, GR may
receive input from signaling pathways that regulate its
transcriptional activity, either in the form of posttransla-
tional modifications or cofactor interactions [26]. This
could occur in the nucleoplasm, or it could occur during
the movement of GR through the cytoplasm during its
shuttling cycle. The latter scenario would obviate the
requirement for nuclear import of cytoplasmic enzymes
or cofactors, possibly to ensure spatial separation from the
nuclear receptors. BecauseGR, AR, andRAR all shuttle in
the presence of their respective ligand, nucleocytoplasmic
shuttling is predicted to be a general property of nuclear
not to the export-defective mutant DBD (FF→AA) from GR. A
preparation of recombinant Crm1 that binds the leucine-rich NES
[39] does not bind to the DBD from GR. Shown are 5% of the total
input proteins (CRT or Crm1). (b) CRT stimulates nuclear export
of wt but not the export-defective mutant of GR in living cells. Cos
cells transfected with GR (wt or FF→AA mutant) fused to GFP were
treated with Dex to induce nuclear import. Following Dex withdrawal,
the cells were microinjected with either His-tagged CRT or His-
tagged Crm1 (1 mg/ml each), and the distribution of GR-GFP was
examined after 30 min. A 70 kDa fluorescent dextran (Cascade
Blue) was included to mark the injection site and to verify that the
nuclear envelope remained intact during the experiment. CRT-
dependent export of wt GR was observed in 30/30 cells injected,
whereas CRT-dependent export of the mutant GR (FF→AA) was
observed in only 2/21 cells injected (three experiments). GR did not
undergo nuclear export in uninjected cells (white arrowheads) or
Crm1-injected cells in this assay. The latter control is consistent with
Crm1-independent export of GR [16, 17]. (c) Shared mechanism
for nuclear export of GR and VDR. A cell line expressing GR-GFP
[35] was permeabilized with digitonin and incubated withThe DBD export signal is necessary for export mediated by CRT. (a)
recombinant CRT (100 g/ml) in the absence and presence of theDirect binding of CRT to the GR DBD. GST fusion proteins
DBD from VDR (120 g/ml). CRT-dependent export of GR-GFP iscontaining the GR DBD (wt or FF→AA) were immobilized on
blocked by the VDR DBD.glutathione-Sepharose beads and used for binding assays with
recombinant CRT and Crm1. CRT binds to the wt DBD from GR but
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Figure 6 Figure 7
Blocking GR export increases ligand-induced gene expression. (a)
VDR-DBD expression increases GR-mediated gene expression over
a wide range of Dex concentration. Endogenous GR activity was
examined in NIH3T3 cells using a GRE-luciferase reporter. Cells
were cotransfected in 6 well dishes with plasmids encoding a Renilla-
luciferase reporter (30 ng), GRE-firefly luciferase (370 ng), and either
BFP alone or BFP-VDR DBD (1000 ng), and then they were incubated
overnight. Cells were lysed 6 hr following the addition of the indicated
amount of Dex. (b) Increasing input pBFP-VDR DBD increases Dex-
induced gene expression. Transfectants were incubated overnight
and then treated with Dex (500 nM) for 6 hr prior to lysis. (c) Expression
of a VDR DBD mutant that fails to compete for GR DBD-mediated
nuclear export only slightly increases Dex-induced gene expression.
Plasmids encoding either wt or FF→AA mutant versions of BFP-
VDR DBD (500 ng each) were transfected and assayed as above. All
luciferase assays were normalized for transfection efficiency using
Renilla-luciferase expression. The values shown represent the fold
induction by the addition of Dex and are the averages of triplicate
wells plus or minus the standard deviation.
Competition for DBD-mediated export in vivo. The GFP reporter
engineered with the DBD of GR was cotransfected with a plasmid
encoding BFP alone (no DBD) or BFP fused to the DBD of VDR in receptors. This would integrate cytoplasmic signaling
Cos cells. Images were captured at 0 and 5 hr following Dex events with regulation of nuclear transcription [27]. Alter-
withdrawal. BFP alone did not alter import of the reporter alone (data natively, the function of DBD-dependent export may re-not shown) or the import and export of the reporter containing the
late to cytoplasmic functions for nuclear receptors thatDBD of GR. The DBD of VDR (VDR-DBD [wt]) blocks GR DBD-
mediated nuclear export. However, a mutant VDR DBD that has two may be transcription-independent [28–30].
critical phenylalanines replaced with alanines (VDR-DBD [FF→AA])
does not compete for GR DBD-mediated nuclear export. Our finding that the DBD of nuclear receptors performs
dual targeting functions in the cell is not without prece-
dent. The DBD in Gal4 contains an NLS, and the DBD
in Stat1 contains a leucine-rich NES that targets it for
export by the Crm1 pathway [31, 32]. Thus, protein do-
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fusion, in order to induce nuclear accumulation of the reporter proteins.mains that bind DNA provide suitable structures for pre-
Cells were incubated at 37C for 4 hr postfusion in the presence of thesenting signals to the nuclear transport machinery. Nu-
indicated nuclear receptor ligands and 10 g/ml cyclohexamide to block
clear transport receptor binding to a DBD-containing protein synthesis. Cells were then fixed and processed for fluorescence
protein should, in addition, block the interaction of the microscopy. AR was expressed with an N-terminal FLAG epitope and
detected by indirect immunofluorescence using the monoclonal antibodyprotein with DNA. In the case of GR and probably other
M2 (Sigma) at a dilution of 1:2000. Goat anti-mouse fluorescein conju-nuclear receptors, this may impart negative regulation on
gated secondary antibody (Pierce) was used at a dilution of 1:100. GR
transcription even prior to nuclear export [18–20]. Nuclear and RAR were expressed as GFP fusions and detected in the FITC
export facilitated by DBDs and nuclear import facilitated channel. The examples shown are representative of 10–25 heterokaryons
from two or more independent experiments.by ligand-regulated NLSs illustrate how simple nuclear
transport-based mechanisms are used to regulate the ac-
Microinjection analysistivity of a superfamily of transcriptional activators and
Cos7 cells were transfected with the indicated vectors and grown over-
influence gene expression in multiple biological path- night in 60 mM dishes; 1.2  105 cells per 35 mM dish were seeded
ways. onto gridded coverslips and grown overnight. Cells were treated with
1 M Dex for 45 min to induce nuclear import of the reporter proteins.
Following Dex withdrawal, cells were microinjected with the indicatedMaterials and methods
transport factors and a cascade blue injection marker (1 mg/ml; MW70
Nuclear receptor cDNAs kDa) using femptotips mounted on a Micromanipulator and Transjector
The DBD from human GR was subcloned from the previously described (Eppendorf). Cells were incubated 30 min at 37C and then fixed and
plasmid pK7-GR-GFP [33]. The GenBank accession numbers corre- processed for fluorescence microscopy.
sponding to the other nuclear receptor superfamily members used for
the DBD analysis are: rat AR, M23264; rat ER, NM_012689; human
Recombinant proteinsLXR, NM_005693; human PR, NM_000926; human RAR,
Mouse CRT was subcloned in pQE-30 (Qiagen) for expression as aNM_000964; human RevErbA, X72631; human RXR, NM_002957;
His-tagged protein in the TG1 E. coli strain. Cultures were grown inhuman TR, X04707; and human VDR, NM_000376. Mutations were
Luria Broth for 24 hr at 37C without induction, and His-CRT was purifiedmade using the QuickChange system (Stratagene).
on TALON beads (Clontech), eluted with imidazole, and dialyzed into
50 mM Hepes (pH 7.4). The expression and purification of His-Crm1Nuclear export assays
has been described [36]. Recombinant transport factors were flash-In vivo export assays
frozen in single-use aliquots and stored at –80C. The nuclear receptorThe reporter used to test DBD-mediated nuclear export has been de-
DBDs were expressed in E. coli as GST fusions by using pGEX-2T andscribed [17] and is derived from the plasmid pXM10 [34]. Cos7 cells
pGEX-4T vectors (Pharmacia). Cells were grown in Luria Broth, andwere seeded onto coverslips and grown overnight prior to transfection
protein expression was induced when OD600 reached 0.5, with 1 mMof the reporter vectors using the transfection reagent Fugene 6 (Roche).
IPTG. The cells were collected by centrifugation, resuspended in lysisAll BFP-DBD competition experiments used plasmids derived from
buffer (25 mM Tris [pH 7.5] and 150 mM sodium chloride), and sonicatedpEBFP-C (Clontech). The transfectants were grown overnight prior to
at 5C until lysis was complete. The lysate was centrifuged at 15,000 gaddition of Dex (1 M) for 45–60 min. Cells were washed five times
for 60 min, and the supernatant was loaded onto a glutathione-Sepharosewith serum-free and phenol red-free Dulbecco’s modified eagle medium
column. The column was equilibrated and washed extensively with the(DMEM) and incubated for the indicated times in phenol red-free DMEM
lysis buffer, and GST-DBDs were eluted with the same buffer supple-containing 10g/ml cyclohexamide and 10% charcoal stripped newborn
mented with 10 mM fresh glutathione. The GST-DBD proteins, in somecalf or fetal bovine serum. Cells were fixed in formaldehyde (3.7%) and
cases, were cleaved with thrombin (Sigma) to generate the free DBDs.processed for fluorescence microscopy. Digital images were captured
The GST and thrombin were removed using a strong cation exchangeby a charge-coupled device camera (Hamamatsu ORCA) mounted on a
media SP-Sepharose (Pharmacia). The column was developed with 25Nikon Microphot-SA microscope, with Openlab (version 2.0.6) software.
mM Tris buffer and a 150–500 mM sodium chloride gradient, with theFigures were assembled with Adobe Photoshop (version 5.5) and Free-
GST and thrombin eluting at the beginning of the gradient and the freehand (version 9). The examples shown are representative of 20–50 cells
DBDs eluting at 300–350 mM sodium chloride.observed in two or more independent experiments.
In vitro export assays Binding assays
His-CRT or His-Crm1 (each at 1 g/ml) proteins were incubated for 30A cell line expressing GR-GFP [35] was treated with 1 M Dex for 45
min. Cells were permeabilized with 0.005% digitonin for 5.5 min. Export min at 4C with the indicated GST proteins immobilized on glutathione-
Sepharose beads. Binding reactions were carried out in 0.5X transportreactions were performed at 30C for 30 min in transport buffer (20
mM Hepes [pH 7.4], 110 mM potassium acetate, 2 mM magnesium buffer supplemented with 10 mg/ml bovine serum albumin, 2 mM DTT,
and 0.2% Tween-20. Beads were subsequently washed three times,acetate, and 1 mM EGTA) supplemented with an ATP-regeneration
system, 2 mM dithiothreitol (DTT), and a protease inhibitor cocktail includ- and bound proteins were eluted with SDS-PAGE sample buffer and
analyzed by Western blotting. CRT was detected using an anti-CRTing aprotinin, leupeptin, and pepstatin (each at 1 g/ml). GFP images
were captured with the same exposure times. rabbit polyclonal antibody (Stressgen), and Crm1 was detected using
an anti-Crm1 rabbit polyclonal antibody (kindly provided by Ralph Kehlen-
bach, Scripps) [37].Heterokaryon analysis
The modified interspecies heterokaryon analysis was performed as fol-
lows. NIH3T3 cells were labeled in tissue culture dishes with 500 nM Luciferase assays
Transcriptional reporter activity was measured by using the Dual-Lucifer-CellTracker dye, (5 (and 6)-(((4-chloromethyl) benzoyl) amino) tetrameth-
ylrhodamine (CMTMR; Molecular Probes), according to the manufactur- ase Reporter Assay System (Promega) according to the manufacturer’s
directions. NIH3T3 cells were seeded at 2  105 per well of a 6 wellers instructions. Unincorporated dye was removed and cells were trypsin-
ized and coseeded on glass coverslips with Cos7 cells that had been dish and grown overnight prior to transfection. Transfections of the
indicated plasmids were performed with the Cytofectene transfectiontransfected with the indicated plasmids using the transfection reagent
Fugene 6 (Roche). Equal numbers of each cell type were seeded for a reagent (Bio Rad). The Renilla-luciferase (R-Luc; Promega) and GRE-
luciferase (generously provided by Gordon Hager, NIH) reporter vectorstotal of 3  105 cells per 35 mm dish and grown overnight prior to
fusion. The indicated ligands were added to the cells 45 min prior to were used in all cases. The total input DNA was 1.4 g per well in
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Calreticulin inhibits vitamin D3 signal transduction. Nucleiceach experiment. Transfectants were grown overnight in phenol red-free
Acids Res 1995, 23:3268-3274.DMEM containing 10% charcoal stripped fetal bovine serum prior to the
21. Omichinski JG, Clore GM, Schaad O, Felsenfeld G, Trainor C, Appellaindicated Dex treatments. Cells were washed with phosphate-buffered
E, et al.: NMR structure of a specific DNA complex of Zn-saline and lysed with 300 l passive lysis buffer (Promega). Luciferase
containing DNA binding domain of GATA-1. Science 1993,
activities were measured by using a Berthold LB 953 luminometer. 261:438-446.
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